478 related articles for article (PubMed ID: 9769897)
41. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
42. [Specific control of gene expression by oligonucleotides: from chemistry to clinical aspects].
Hélène C
Ann Pharm Fr; 1997; 55(3):95-103. PubMed ID: 9239858
[TBL] [Abstract][Full Text] [Related]
43. [Applications of antisense oligonucleotides in oncology].
Pierga JY; Cammilleri S; Benyahia B; Magdelénat H
Bull Cancer; 1994 Dec; 81(12):1023-42. PubMed ID: 7742591
[TBL] [Abstract][Full Text] [Related]
44. Antisense oligonucleotide technology in the development of cancer therapeutics.
Tseng BY; Brown KD
Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240
[No Abstract] [Full Text] [Related]
45. Antisense oligonucleotide technology: from EST to therapeutics.
Giles RV
Curr Opin Mol Ther; 2000 Jun; 2(3):238-52. PubMed ID: 11249617
[TBL] [Abstract][Full Text] [Related]
46. The application of locked nucleic acids in the treatment of cancer.
Frieden M; Orum H
IDrugs; 2006 Oct; 9(10):706-11. PubMed ID: 17016778
[TBL] [Abstract][Full Text] [Related]
47. [Antisense oligonucleotides arrest the synthesis of disease promoting proteins].
Schnädelbach S
Med Monatsschr Pharm; 1998 Dec; 21(12):394-5. PubMed ID: 9925458
[No Abstract] [Full Text] [Related]
48. Peptide nucleic acids as therapeutic agents.
Nielsen PE
Curr Opin Struct Biol; 1999 Jun; 9(3):353-7. PubMed ID: 10361091
[TBL] [Abstract][Full Text] [Related]
49. Technology evaluation: AVI-4126, AVI BioPharma.
Stephens AC
Curr Opin Mol Ther; 2004 Oct; 6(5):551-8. PubMed ID: 15537057
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of the androgen receptor by antisense oligonucleotides regulates the biological activity of androgens in SZ95 sebocytes.
Fimmel S; Saborowski A; Térouanne B; Sultan C; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):149-56. PubMed ID: 17326011
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers.
Amantana A; Iversen PL
Curr Opin Pharmacol; 2005 Oct; 5(5):550-5. PubMed ID: 16087398
[TBL] [Abstract][Full Text] [Related]
52. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides.
White PJ; Anastasopoulos F; Pouton CW; Boyd BJ
Expert Rev Mol Med; 2009 Mar; 11():e10. PubMed ID: 19302730
[TBL] [Abstract][Full Text] [Related]
53. Antisense approaches to immune modulation for transplant and autoimmune diseases.
Mourich DV; Marshall NB
Curr Opin Pharmacol; 2005 Oct; 5(5):508-12. PubMed ID: 16087396
[TBL] [Abstract][Full Text] [Related]
54. GTI-2040. Lorus Therapeutics.
Orr RM
Curr Opin Investig Drugs; 2001 Oct; 2(10):1462-6. PubMed ID: 11890366
[TBL] [Abstract][Full Text] [Related]
55. Brief overview of control of genetic expression by antisense oligonucleotides and in vivo applications. Prospects for neurobiology.
Zon G
Mol Neurobiol; 1995; 10(2-3):219-29. PubMed ID: 7576309
[TBL] [Abstract][Full Text] [Related]
56. Antisense oligonucleotides: the state of the art.
Aboul-Fadl T
Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
[TBL] [Abstract][Full Text] [Related]
57. [Control of gene expression by antisense nucleic acids].
Lebleu B; Clarenc JP; Degols G; Leonetti JP; Milhaud P
C R Seances Soc Biol Fil; 1992; 186(5):560-6. PubMed ID: 1305901
[TBL] [Abstract][Full Text] [Related]
58. Gene technology: chances for diagnosis and therapy.
Werner RG
Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):525-37. PubMed ID: 7885080
[TBL] [Abstract][Full Text] [Related]
59. [Prospects of a more selective chemotherapy with antisense oligonucleotides].
Le Doan T; Etoré F; David DF; Tenu JP
Ann Med Interne (Paris); 1996; 147(8):542-52. PubMed ID: 9137681
[No Abstract] [Full Text] [Related]
60. PAcM-AN: poly (N-acryloylmorpholine)-conjugated antisense oligonucleotides.
Bonora GM; De Franco AM; Rossin R; Veronese FM; Ferruti P; Plyasunova O; Vorobjev PE; Pyshnyi DV; Komarova NI; Zarytova VF
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1281-8. PubMed ID: 11097058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
